Kingsview Wealth Management LLC acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 96,996 shares of the company’s stock, valued at approximately $2,906,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. AQR Capital Management LLC increased its holdings in Bath & Body Works by 267.8% in the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after acquiring an additional 2,907,506 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in Bath & Body Works by 115.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock worth $111,581,000 after acquiring an additional 1,973,679 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its position in Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after purchasing an additional 781,681 shares during the period. Nuveen LLC purchased a new stake in Bath & Body Works in the 1st quarter worth approximately $23,273,000. Finally, Boston Partners raised its holdings in Bath & Body Works by 289.7% in the 1st quarter. Boston Partners now owns 937,024 shares of the company’s stock worth $28,292,000 after purchasing an additional 696,555 shares during the period. 95.14% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the stock. Wells Fargo & Company reduced their target price on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research report on Monday, October 27th. UBS Group lowered their price target on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a report on Friday, August 29th. Citigroup reduced their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, August 19th. JPMorgan Chase & Co. restated a “neutral” rating and set a $26.00 price target on shares of Bath & Body Works in a research note on Monday, October 6th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Ten analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $38.18.
Bath & Body Works Price Performance
NYSE BBWI opened at $21.09 on Wednesday. The company has a fifty day moving average of $25.21 and a two-hundred day moving average of $28.39. The company has a market capitalization of $4.35 billion, a PE ratio of 6.26, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a 1 year low of $20.85 and a 1 year high of $41.87.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting the consensus estimate of $0.37. The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm’s revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 23.74%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Five stocks we like better than Bath & Body Works
- The 3 Best Fintech Stocks to Buy Now
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- What to Know About Investing in Penny Stocks
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- Technology Stocks Explained: Here’s What to Know About Tech
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
